The year 2014 has again provided important developments in the area of prostate cancer. New data and new treatments span the spectrum of prostate cancer management, from prevention and screening to optimal strategies for localized, locally advanced, and metastatic disease. Read the article. (Free Medscape account required.)
Advances in Prostate Cancer: 2014 Read More »
Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter. In this Issue: 20th Anniversary Highlighted by November Scotiabank awareness Night Celebrations – including photos PCCN-Toronto’s Postition on PSA Testing Dr. Andrew Feifer – January Awareness Night – Testing Procedure and Diagnosing Prostate Cancer Another Successful Toronto Wake-up Call Breakfast Blue Wrist Bands Holiday Wishes from out Chairman 2015 Scotiabank Awareness Nights Schedule Read it by clicking the link below to open the pdf file: December_2014_Newsletter
Newsletter December 2014 Read More »
Metabolites in the essential mineral selenium may help the body fight certain kinds of cancer, say researchers at the University of Copenhagen. Selenium is found naturally in a number of vegetables and nuts, as well as in fish such as salmon, tuna and cod. Read the article.
Essential mineral found in salmon, broccoli and other foods may help fight cancer Read More »
The challenge in prostate cancer (PCa) is to match the aggressiveness of the treatment to that of the cancer. Until recently, all screen-diagnosed localized cancers were considered at least potentially aggressive and in most cases were treated radically. Active surveillance represented a major step forward in acknowledging that some cancers were clinically insignificant and did not pose a threat to the patient’s life. Recently, a third option—focal therapy—has emerged as a potential middle ground between radical treatment and active surveillance. Read the article.
(TORONTO, Canada – Nov. 13, 2014) – Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy. Read the article.
Prostate cancer researchers develop personalized genetic test to predict recurrence risk Read More »
This is one of Dr. Snuffy Meyer’s videos about prostate cancer. Dr. Snuffy Myers talks about why the flu vaccine is so important for prostate cancer patients. Click here to view video.
Flu Vaccine + Prostate Cancer Read More »
In recent years, various task forces or panels have come out strongly against using the PSA blood test as a screening tool. The latest was the Canadian Task Force on Preventive Health Care (CTFPHC) which, on Monday October 27th, 2014 stated that this test should not be used, as it does not prove to save lives!
Our Position on PSA Screening Read More »
Department of Surgery, University of Toronto, Humber River Hospital, Toronto, Ontario, Canada BARKIN J. How I Do It: Managing bone health in patients with prostate cancer. Can J Urol 2014;21(4): 7399-7403. Urologists have two scenarios where they have to address bone loss or increased risk of fractures in men with prostate cancer. In the first setting, a patient who has been started on androgen deprivation therapy may develop cancer-treatment-induced bone loss. In the second setting, a patient’s prostate cancer may have metastasized to the bone. This article describes six steps to manage bone health in patients diagnosed with prostate cancer
Managing bone health in patients with prostate cancer Read More »
Salvage radiation therapy (SRT) given after radical prostatectomy may improve outcomes in prostate cancer (PCa) patients, even in those who fail the treatment, according to study findings presented at the 56th annual meeting of the American Society for Radiation Oncology in San Francisco. Read the article.
Good Prostate Cancer Outcomes Possible Despite Salvage Radiation Failure Read More »
Low-dose aspirin use is independently associated with decreased acute genitourinary (GU) toxicity in patients undergoing radiotherapy for prostate cancer (PCa), researchers reported at the American Society for Radiation Oncology 56th annual meeting in San Francisco. Read the article.
Aspirin Eases Genitourinary Toxicity from Prostate Cancer Radiotherapy Read More »